nodes	percent_of_prediction	percent_of_DWPC	metapath
Nadolol—ABCB1—Dactinomycin—sarcoma	0.187	0.289	CbGbCtD
Nadolol—ABCB1—Mitoxantrone—sarcoma	0.167	0.259	CbGbCtD
Nadolol—ABCB1—Vincristine—sarcoma	0.115	0.178	CbGbCtD
Nadolol—ABCB1—Etoposide—sarcoma	0.106	0.163	CbGbCtD
Nadolol—ABCB1—Doxorubicin—sarcoma	0.072	0.111	CbGbCtD
Nadolol—Alopecia reversible—Etoposide—sarcoma	0.0153	0.0435	CcSEcCtD
Nadolol—Alopecia reversible—Epirubicin—sarcoma	0.0086	0.0244	CcSEcCtD
Nadolol—Alopecia reversible—Doxorubicin—sarcoma	0.00795	0.0225	CcSEcCtD
Nadolol—Respiratory distress—Vincristine—sarcoma	0.00677	0.0192	CcSEcCtD
Nadolol—Cardiomegaly—Epirubicin—sarcoma	0.00535	0.0152	CcSEcCtD
Nadolol—Cardiomegaly—Doxorubicin—sarcoma	0.00495	0.014	CcSEcCtD
Nadolol—Laryngospasm—Etoposide—sarcoma	0.00466	0.0132	CcSEcCtD
Nadolol—Fluid retention—Thiotepa—sarcoma	0.0046	0.013	CcSEcCtD
Nadolol—Hepatic enzyme increased—Mitoxantrone—sarcoma	0.00443	0.0125	CcSEcCtD
Nadolol—Pulmonary oedema—Thiotepa—sarcoma	0.00431	0.0122	CcSEcCtD
Nadolol—Cardiac failure—Thiotepa—sarcoma	0.00361	0.0102	CcSEcCtD
Nadolol—Lethargy—Dactinomycin—sarcoma	0.00356	0.0101	CcSEcCtD
Nadolol—Cardiac failure congestive—Mitoxantrone—sarcoma	0.00335	0.00949	CcSEcCtD
Nadolol—Cardiac failure—Mitoxantrone—sarcoma	0.00311	0.00882	CcSEcCtD
Nadolol—Cardiac failure congestive—Etoposide—sarcoma	0.00279	0.0079	CcSEcCtD
Nadolol—Weight increased—Thiotepa—sarcoma	0.00277	0.00784	CcSEcCtD
Nadolol—Conjunctivitis—Thiotepa—sarcoma	0.00264	0.00747	CcSEcCtD
Nadolol—Cardiac failure—Etoposide—sarcoma	0.00259	0.00734	CcSEcCtD
Nadolol—Agranulocytosis—Thiotepa—sarcoma	0.00253	0.00717	CcSEcCtD
Nadolol—Agranulocytosis—Dactinomycin—sarcoma	0.00251	0.00712	CcSEcCtD
Nadolol—Erectile dysfunction—Vincristine—sarcoma	0.00248	0.00704	CcSEcCtD
Nadolol—Hallucination—Thiotepa—sarcoma	0.00242	0.00686	CcSEcCtD
Nadolol—Erectile dysfunction—Mitoxantrone—sarcoma	0.00242	0.00685	CcSEcCtD
Nadolol—Depression—Vincristine—sarcoma	0.0024	0.00679	CcSEcCtD
Nadolol—Weight increased—Mitoxantrone—sarcoma	0.00239	0.00677	CcSEcCtD
Nadolol—Sweating—Vincristine—sarcoma	0.0023	0.00653	CcSEcCtD
Nadolol—Conjunctivitis—Mitoxantrone—sarcoma	0.00228	0.00645	CcSEcCtD
Nadolol—Tinnitus—Thiotepa—sarcoma	0.00227	0.00643	CcSEcCtD
Nadolol—Sweating—Mitoxantrone—sarcoma	0.00224	0.00636	CcSEcCtD
Nadolol—Agranulocytosis—Mitoxantrone—sarcoma	0.00219	0.00619	CcSEcCtD
Nadolol—Ventricular extrasystoles—Epirubicin—sarcoma	0.00216	0.00612	CcSEcCtD
Nadolol—Alopecia—Thiotepa—sarcoma	0.00215	0.00609	CcSEcCtD
Nadolol—Bronchospasm—Etoposide—sarcoma	0.00215	0.00609	CcSEcCtD
Nadolol—Hallucination—Vincristine—sarcoma	0.00215	0.00609	CcSEcCtD
Nadolol—Bradycardia—Mitoxantrone—sarcoma	0.00214	0.00606	CcSEcCtD
Nadolol—Alopecia—Dactinomycin—sarcoma	0.00213	0.00605	CcSEcCtD
Nadolol—Dysarthria—Epirubicin—sarcoma	0.00206	0.00585	CcSEcCtD
Nadolol—Atrioventricular block—Epirubicin—sarcoma	0.00201	0.0057	CcSEcCtD
Nadolol—Ventricular extrasystoles—Doxorubicin—sarcoma	0.002	0.00567	CcSEcCtD
Nadolol—Vision blurred—Thiotepa—sarcoma	0.002	0.00566	CcSEcCtD
Nadolol—Dysarthria—Doxorubicin—sarcoma	0.00191	0.00541	CcSEcCtD
Nadolol—Alopecia—Vincristine—sarcoma	0.00191	0.0054	CcSEcCtD
Nadolol—Atrioventricular block—Doxorubicin—sarcoma	0.00186	0.00528	CcSEcCtD
Nadolol—Alopecia—Mitoxantrone—sarcoma	0.00186	0.00526	CcSEcCtD
Nadolol—Fluid retention—Epirubicin—sarcoma	0.00185	0.00525	CcSEcCtD
Nadolol—Cough—Thiotepa—sarcoma	0.00185	0.00524	CcSEcCtD
Nadolol—Hypertension—Thiotepa—sarcoma	0.00183	0.00518	CcSEcCtD
Nadolol—Agranulocytosis—Etoposide—sarcoma	0.00182	0.00515	CcSEcCtD
Nadolol—Dry eye—Epirubicin—sarcoma	0.0018	0.00511	CcSEcCtD
Nadolol—Pulmonary oedema—Epirubicin—sarcoma	0.00174	0.00492	CcSEcCtD
Nadolol—Vision blurred—Mitoxantrone—sarcoma	0.00172	0.00489	CcSEcCtD
Nadolol—Oedema—Dactinomycin—sarcoma	0.00172	0.00486	CcSEcCtD
Nadolol—Fluid retention—Doxorubicin—sarcoma	0.00171	0.00486	CcSEcCtD
Nadolol—Dry eye—Doxorubicin—sarcoma	0.00167	0.00473	CcSEcCtD
Nadolol—Anorexia—Thiotepa—sarcoma	0.00165	0.00467	CcSEcCtD
Nadolol—Anorexia—Dactinomycin—sarcoma	0.00164	0.00464	CcSEcCtD
Nadolol—Hypertension—Vincristine—sarcoma	0.00162	0.0046	CcSEcCtD
Nadolol—Pulmonary oedema—Doxorubicin—sarcoma	0.00161	0.00455	CcSEcCtD
Nadolol—Cough—Mitoxantrone—sarcoma	0.0016	0.00452	CcSEcCtD
Nadolol—Hypertension—Mitoxantrone—sarcoma	0.00158	0.00448	CcSEcCtD
Nadolol—Cardiac failure congestive—Epirubicin—sarcoma	0.00156	0.00443	CcSEcCtD
Nadolol—Chest pain—Mitoxantrone—sarcoma	0.00156	0.00441	CcSEcCtD
Nadolol—Paraesthesia—Thiotepa—sarcoma	0.00155	0.0044	CcSEcCtD
Nadolol—Alopecia—Etoposide—sarcoma	0.00154	0.00438	CcSEcCtD
Nadolol—Oedema—Vincristine—sarcoma	0.00153	0.00435	CcSEcCtD
Nadolol—Dyspepsia—Thiotepa—sarcoma	0.00152	0.00431	CcSEcCtD
Nadolol—Decreased appetite—Thiotepa—sarcoma	0.0015	0.00426	CcSEcCtD
Nadolol—Oedema—Mitoxantrone—sarcoma	0.00149	0.00423	CcSEcCtD
Nadolol—Decreased appetite—Dactinomycin—sarcoma	0.00149	0.00423	CcSEcCtD
Nadolol—Fatigue—Thiotepa—sarcoma	0.00149	0.00422	CcSEcCtD
Nadolol—Hyperhidrosis—Vincristine—sarcoma	0.00148	0.0042	CcSEcCtD
Nadolol—Fatigue—Dactinomycin—sarcoma	0.00148	0.00419	CcSEcCtD
Nadolol—Pain—Thiotepa—sarcoma	0.00148	0.00419	CcSEcCtD
Nadolol—Constipation—Thiotepa—sarcoma	0.00148	0.00419	CcSEcCtD
Nadolol—Shock—Mitoxantrone—sarcoma	0.00147	0.00416	CcSEcCtD
Nadolol—Pain—Dactinomycin—sarcoma	0.00147	0.00416	CcSEcCtD
Nadolol—Anorexia—Vincristine—sarcoma	0.00146	0.00414	CcSEcCtD
Nadolol—Cardiac failure—Epirubicin—sarcoma	0.00145	0.00411	CcSEcCtD
Nadolol—Lethargy—Epirubicin—sarcoma	0.00145	0.0041	CcSEcCtD
Nadolol—Cardiac failure congestive—Doxorubicin—sarcoma	0.00145	0.0041	CcSEcCtD
Nadolol—Hyperhidrosis—Mitoxantrone—sarcoma	0.00144	0.00409	CcSEcCtD
Nadolol—Hypotension—Vincristine—sarcoma	0.00143	0.00406	CcSEcCtD
Nadolol—Anorexia—Mitoxantrone—sarcoma	0.00142	0.00403	CcSEcCtD
Nadolol—Diplopia—Epirubicin—sarcoma	0.00142	0.00401	CcSEcCtD
Nadolol—Hypotension—Mitoxantrone—sarcoma	0.0014	0.00395	CcSEcCtD
Nadolol—Affect lability—Epirubicin—sarcoma	0.00139	0.00395	CcSEcCtD
Nadolol—Insomnia—Vincristine—sarcoma	0.00139	0.00393	CcSEcCtD
Nadolol—Paraesthesia—Vincristine—sarcoma	0.00138	0.0039	CcSEcCtD
Nadolol—Body temperature increased—Thiotepa—sarcoma	0.00137	0.00387	CcSEcCtD
Nadolol—Body temperature increased—Dactinomycin—sarcoma	0.00136	0.00384	CcSEcCtD
Nadolol—Cardiac failure—Doxorubicin—sarcoma	0.00134	0.00381	CcSEcCtD
Nadolol—Mood swings—Epirubicin—sarcoma	0.00134	0.0038	CcSEcCtD
Nadolol—Paraesthesia—Mitoxantrone—sarcoma	0.00134	0.0038	CcSEcCtD
Nadolol—Loss of consciousness—Etoposide—sarcoma	0.00134	0.00379	CcSEcCtD
Nadolol—Lethargy—Doxorubicin—sarcoma	0.00134	0.00379	CcSEcCtD
Nadolol—Decreased appetite—Vincristine—sarcoma	0.00133	0.00378	CcSEcCtD
Nadolol—Dyspnoea—Mitoxantrone—sarcoma	0.00133	0.00377	CcSEcCtD
Nadolol—Cough—Etoposide—sarcoma	0.00133	0.00376	CcSEcCtD
Nadolol—Fatigue—Vincristine—sarcoma	0.00132	0.00375	CcSEcCtD
Nadolol—Dyspepsia—Mitoxantrone—sarcoma	0.00131	0.00372	CcSEcCtD
Nadolol—Hypertension—Etoposide—sarcoma	0.00131	0.00372	CcSEcCtD
Nadolol—Pain—Vincristine—sarcoma	0.00131	0.00372	CcSEcCtD
Nadolol—Constipation—Vincristine—sarcoma	0.00131	0.00372	CcSEcCtD
Nadolol—Diplopia—Doxorubicin—sarcoma	0.00131	0.00371	CcSEcCtD
Nadolol—Dry skin—Epirubicin—sarcoma	0.0013	0.00368	CcSEcCtD
Nadolol—Decreased appetite—Mitoxantrone—sarcoma	0.0013	0.00368	CcSEcCtD
Nadolol—Chest pain—Etoposide—sarcoma	0.0013	0.00367	CcSEcCtD
Nadolol—Affect lability—Doxorubicin—sarcoma	0.00129	0.00366	CcSEcCtD
Nadolol—Fatigue—Mitoxantrone—sarcoma	0.00129	0.00365	CcSEcCtD
Nadolol—Pain—Mitoxantrone—sarcoma	0.00128	0.00362	CcSEcCtD
Nadolol—Constipation—Mitoxantrone—sarcoma	0.00128	0.00362	CcSEcCtD
Nadolol—Gastritis—Epirubicin—sarcoma	0.00125	0.00355	CcSEcCtD
Nadolol—Mood swings—Doxorubicin—sarcoma	0.00124	0.00352	CcSEcCtD
Nadolol—Asthenia—Thiotepa—sarcoma	0.00124	0.00352	CcSEcCtD
Nadolol—Abdominal distension—Epirubicin—sarcoma	0.00123	0.00349	CcSEcCtD
Nadolol—Asthenia—Dactinomycin—sarcoma	0.00123	0.00349	CcSEcCtD
Nadolol—Pruritus—Thiotepa—sarcoma	0.00122	0.00347	CcSEcCtD
Nadolol—Body temperature increased—Vincristine—sarcoma	0.00121	0.00343	CcSEcCtD
Nadolol—Dry skin—Doxorubicin—sarcoma	0.0012	0.0034	CcSEcCtD
Nadolol—Hyperhidrosis—Etoposide—sarcoma	0.0012	0.0034	CcSEcCtD
Nadolol—Anorexia—Etoposide—sarcoma	0.00118	0.00336	CcSEcCtD
Nadolol—Diarrhoea—Thiotepa—sarcoma	0.00118	0.00335	CcSEcCtD
Nadolol—Body temperature increased—Mitoxantrone—sarcoma	0.00118	0.00335	CcSEcCtD
Nadolol—Diarrhoea—Dactinomycin—sarcoma	0.00117	0.00333	CcSEcCtD
Nadolol—Hypotension—Etoposide—sarcoma	0.00116	0.00329	CcSEcCtD
Nadolol—Gastritis—Doxorubicin—sarcoma	0.00116	0.00329	CcSEcCtD
Nadolol—Dizziness—Thiotepa—sarcoma	0.00114	0.00324	CcSEcCtD
Nadolol—Abdominal distension—Doxorubicin—sarcoma	0.00114	0.00323	CcSEcCtD
Nadolol—Paraesthesia—Etoposide—sarcoma	0.00112	0.00316	CcSEcCtD
Nadolol—Weight increased—Epirubicin—sarcoma	0.00111	0.00316	CcSEcCtD
Nadolol—Dyspnoea—Etoposide—sarcoma	0.00111	0.00314	CcSEcCtD
Nadolol—Asthenia—Vincristine—sarcoma	0.0011	0.00312	CcSEcCtD
Nadolol—Vomiting—Thiotepa—sarcoma	0.0011	0.00312	CcSEcCtD
Nadolol—Vomiting—Dactinomycin—sarcoma	0.00109	0.00309	CcSEcCtD
Nadolol—Rash—Thiotepa—sarcoma	0.00109	0.00309	CcSEcCtD
Nadolol—Dermatitis—Thiotepa—sarcoma	0.00109	0.00309	CcSEcCtD
Nadolol—Rash—Dactinomycin—sarcoma	0.00108	0.00307	CcSEcCtD
Nadolol—Decreased appetite—Etoposide—sarcoma	0.00108	0.00306	CcSEcCtD
Nadolol—Asthenia—Mitoxantrone—sarcoma	0.00107	0.00304	CcSEcCtD
Nadolol—Fatigue—Etoposide—sarcoma	0.00107	0.00303	CcSEcCtD
Nadolol—Constipation—Etoposide—sarcoma	0.00106	0.00301	CcSEcCtD
Nadolol—Pain—Etoposide—sarcoma	0.00106	0.00301	CcSEcCtD
Nadolol—Conjunctivitis—Epirubicin—sarcoma	0.00106	0.00301	CcSEcCtD
Nadolol—Diarrhoea—Vincristine—sarcoma	0.00105	0.00297	CcSEcCtD
Nadolol—Sweating—Epirubicin—sarcoma	0.00105	0.00297	CcSEcCtD
Nadolol—Weight increased—Doxorubicin—sarcoma	0.00103	0.00292	CcSEcCtD
Nadolol—Nausea—Thiotepa—sarcoma	0.00103	0.00291	CcSEcCtD
Nadolol—Diarrhoea—Mitoxantrone—sarcoma	0.00102	0.0029	CcSEcCtD
Nadolol—Nausea—Dactinomycin—sarcoma	0.00102	0.00289	CcSEcCtD
Nadolol—Agranulocytosis—Epirubicin—sarcoma	0.00102	0.00289	CcSEcCtD
Nadolol—Dizziness—Vincristine—sarcoma	0.00101	0.00287	CcSEcCtD
Nadolol—Bradycardia—Epirubicin—sarcoma	0.000998	0.00283	CcSEcCtD
Nadolol—Body temperature increased—Etoposide—sarcoma	0.000982	0.00278	CcSEcCtD
Nadolol—Conjunctivitis—Doxorubicin—sarcoma	0.000982	0.00278	CcSEcCtD
Nadolol—Vomiting—Vincristine—sarcoma	0.000975	0.00276	CcSEcCtD
Nadolol—Sweating—Doxorubicin—sarcoma	0.000968	0.00274	CcSEcCtD
Nadolol—Rash—Vincristine—sarcoma	0.000967	0.00274	CcSEcCtD
Nadolol—Dermatitis—Vincristine—sarcoma	0.000966	0.00274	CcSEcCtD
Nadolol—Vomiting—Mitoxantrone—sarcoma	0.000949	0.00269	CcSEcCtD
Nadolol—Visual impairment—Epirubicin—sarcoma	0.000944	0.00268	CcSEcCtD
Nadolol—Agranulocytosis—Doxorubicin—sarcoma	0.000943	0.00267	CcSEcCtD
Nadolol—Rash—Mitoxantrone—sarcoma	0.000942	0.00267	CcSEcCtD
Nadolol—Dermatitis—Mitoxantrone—sarcoma	0.000941	0.00267	CcSEcCtD
Nadolol—Bradycardia—Doxorubicin—sarcoma	0.000923	0.00262	CcSEcCtD
Nadolol—Tinnitus—Epirubicin—sarcoma	0.000914	0.00259	CcSEcCtD
Nadolol—Nausea—Vincristine—sarcoma	0.000911	0.00258	CcSEcCtD
Nadolol—Asthenia—Etoposide—sarcoma	0.000891	0.00253	CcSEcCtD
Nadolol—Nausea—Mitoxantrone—sarcoma	0.000887	0.00251	CcSEcCtD
Nadolol—Pruritus—Etoposide—sarcoma	0.000879	0.00249	CcSEcCtD
Nadolol—Visual impairment—Doxorubicin—sarcoma	0.000874	0.00248	CcSEcCtD
Nadolol—Alopecia—Epirubicin—sarcoma	0.000866	0.00245	CcSEcCtD
Nadolol—Diarrhoea—Etoposide—sarcoma	0.00085	0.00241	CcSEcCtD
Nadolol—Tinnitus—Doxorubicin—sarcoma	0.000845	0.0024	CcSEcCtD
Nadolol—Flatulence—Epirubicin—sarcoma	0.000841	0.00238	CcSEcCtD
Nadolol—Dizziness—Etoposide—sarcoma	0.000821	0.00233	CcSEcCtD
Nadolol—Vision blurred—Epirubicin—sarcoma	0.000804	0.00228	CcSEcCtD
Nadolol—Alopecia—Doxorubicin—sarcoma	0.000801	0.00227	CcSEcCtD
Nadolol—Vomiting—Etoposide—sarcoma	0.00079	0.00224	CcSEcCtD
Nadolol—Rash—Etoposide—sarcoma	0.000783	0.00222	CcSEcCtD
Nadolol—Dermatitis—Etoposide—sarcoma	0.000782	0.00222	CcSEcCtD
Nadolol—Flatulence—Doxorubicin—sarcoma	0.000778	0.0022	CcSEcCtD
Nadolol—Syncope—Epirubicin—sarcoma	0.000765	0.00217	CcSEcCtD
Nadolol—Loss of consciousness—Epirubicin—sarcoma	0.00075	0.00212	CcSEcCtD
Nadolol—Cough—Epirubicin—sarcoma	0.000744	0.00211	CcSEcCtD
Nadolol—Vision blurred—Doxorubicin—sarcoma	0.000744	0.00211	CcSEcCtD
Nadolol—Nausea—Etoposide—sarcoma	0.000738	0.00209	CcSEcCtD
Nadolol—Hypertension—Epirubicin—sarcoma	0.000737	0.00209	CcSEcCtD
Nadolol—Chest pain—Epirubicin—sarcoma	0.000726	0.00206	CcSEcCtD
Nadolol—Dry mouth—Epirubicin—sarcoma	0.00071	0.00201	CcSEcCtD
Nadolol—Syncope—Doxorubicin—sarcoma	0.000708	0.00201	CcSEcCtD
Nadolol—Oedema—Epirubicin—sarcoma	0.000696	0.00197	CcSEcCtD
Nadolol—Loss of consciousness—Doxorubicin—sarcoma	0.000694	0.00197	CcSEcCtD
Nadolol—Cough—Doxorubicin—sarcoma	0.000689	0.00195	CcSEcCtD
Nadolol—Shock—Epirubicin—sarcoma	0.000685	0.00194	CcSEcCtD
Nadolol—Hypertension—Doxorubicin—sarcoma	0.000682	0.00193	CcSEcCtD
Nadolol—Hyperhidrosis—Epirubicin—sarcoma	0.000673	0.00191	CcSEcCtD
Nadolol—Chest pain—Doxorubicin—sarcoma	0.000672	0.0019	CcSEcCtD
Nadolol—Anorexia—Epirubicin—sarcoma	0.000664	0.00188	CcSEcCtD
Nadolol—Dry mouth—Doxorubicin—sarcoma	0.000657	0.00186	CcSEcCtD
Nadolol—Hypotension—Epirubicin—sarcoma	0.000651	0.00184	CcSEcCtD
Nadolol—Oedema—Doxorubicin—sarcoma	0.000644	0.00183	CcSEcCtD
Nadolol—Shock—Doxorubicin—sarcoma	0.000634	0.0018	CcSEcCtD
Nadolol—Insomnia—Epirubicin—sarcoma	0.00063	0.00178	CcSEcCtD
Nadolol—Paraesthesia—Epirubicin—sarcoma	0.000625	0.00177	CcSEcCtD
Nadolol—Hyperhidrosis—Doxorubicin—sarcoma	0.000623	0.00176	CcSEcCtD
Nadolol—Dyspnoea—Epirubicin—sarcoma	0.000621	0.00176	CcSEcCtD
Nadolol—Anorexia—Doxorubicin—sarcoma	0.000614	0.00174	CcSEcCtD
Nadolol—Dyspepsia—Epirubicin—sarcoma	0.000613	0.00174	CcSEcCtD
Nadolol—Decreased appetite—Epirubicin—sarcoma	0.000605	0.00172	CcSEcCtD
Nadolol—Hypotension—Doxorubicin—sarcoma	0.000602	0.00171	CcSEcCtD
Nadolol—Fatigue—Epirubicin—sarcoma	0.0006	0.0017	CcSEcCtD
Nadolol—Constipation—Epirubicin—sarcoma	0.000595	0.00169	CcSEcCtD
Nadolol—Pain—Epirubicin—sarcoma	0.000595	0.00169	CcSEcCtD
Nadolol—Insomnia—Doxorubicin—sarcoma	0.000583	0.00165	CcSEcCtD
Nadolol—Paraesthesia—Doxorubicin—sarcoma	0.000579	0.00164	CcSEcCtD
Nadolol—Dyspnoea—Doxorubicin—sarcoma	0.000574	0.00163	CcSEcCtD
Nadolol—Dyspepsia—Doxorubicin—sarcoma	0.000567	0.00161	CcSEcCtD
Nadolol—Decreased appetite—Doxorubicin—sarcoma	0.00056	0.00159	CcSEcCtD
Nadolol—Fatigue—Doxorubicin—sarcoma	0.000555	0.00157	CcSEcCtD
Nadolol—Constipation—Doxorubicin—sarcoma	0.000551	0.00156	CcSEcCtD
Nadolol—Pain—Doxorubicin—sarcoma	0.000551	0.00156	CcSEcCtD
Nadolol—Body temperature increased—Epirubicin—sarcoma	0.00055	0.00156	CcSEcCtD
Nadolol—Body temperature increased—Doxorubicin—sarcoma	0.000509	0.00144	CcSEcCtD
Nadolol—Asthenia—Epirubicin—sarcoma	0.0005	0.00142	CcSEcCtD
Nadolol—Pruritus—Epirubicin—sarcoma	0.000493	0.0014	CcSEcCtD
Nadolol—Diarrhoea—Epirubicin—sarcoma	0.000476	0.00135	CcSEcCtD
Nadolol—Asthenia—Doxorubicin—sarcoma	0.000462	0.00131	CcSEcCtD
Nadolol—Dizziness—Epirubicin—sarcoma	0.00046	0.0013	CcSEcCtD
Nadolol—Pruritus—Doxorubicin—sarcoma	0.000456	0.00129	CcSEcCtD
Nadolol—Vomiting—Epirubicin—sarcoma	0.000443	0.00125	CcSEcCtD
Nadolol—Diarrhoea—Doxorubicin—sarcoma	0.000441	0.00125	CcSEcCtD
Nadolol—Rash—Epirubicin—sarcoma	0.000439	0.00124	CcSEcCtD
Nadolol—Dermatitis—Epirubicin—sarcoma	0.000439	0.00124	CcSEcCtD
Nadolol—Dizziness—Doxorubicin—sarcoma	0.000426	0.00121	CcSEcCtD
Nadolol—Nausea—Epirubicin—sarcoma	0.000414	0.00117	CcSEcCtD
Nadolol—Vomiting—Doxorubicin—sarcoma	0.00041	0.00116	CcSEcCtD
Nadolol—Rash—Doxorubicin—sarcoma	0.000406	0.00115	CcSEcCtD
Nadolol—Dermatitis—Doxorubicin—sarcoma	0.000406	0.00115	CcSEcCtD
Nadolol—Nausea—Doxorubicin—sarcoma	0.000383	0.00108	CcSEcCtD
